Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors

被引：6

作者：

Thibault, Thomas ^{[1
,2
,3
,9
]}

BEN Ghezala, Ines ^{[4
,5
]}

Freppel, Romane ^{[2
]}

Rajillah, Abdessamad ^{[1
]}

Boulay, Charlene ^{[6
]}

Brunel, Pierre ^{[7
]}

Atzenhoffer, Marina ^{[8
]}

Auvens, Clement ^{[1
]}

Devilliers, Herve ^{[1
,3
]}

Grandvuillemin, Aurelie ^{[2
]}

机构：

[1] Univ Hosp Dijon Burgundy, Internal Med & Syst Dis Unit, Dijon, France

[2] Univ Hosp Dijon Burgundy, Ctr Reg Pharmacovigilance Bourgogne, Dijon, France

[3] Univ Hosp Dijon Burgundy, Clin Invest Ctr, INSERM CIC EC 1432, Dijon, France

[4] Univ Hosp Dijon Burgundy, Univ Hosp, Ophthalmol Dept, Dijon, France

[5] Univ Hosp Dijon Burgundy, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, INSERM,CIC 1432, Dijon, France

[6] CHU Rouen, Reg Ctr Pharmacovigilance & Pharmacoepidemiol, ,Normandie, Rouen, France

[7] CHU St Etienne, Ctr Pharmacovigilance & Renseignements Medicament, St Etienne, Auvergne Rhone, France

[8] Hosp Civils Lyon, Serv Hosp Univ Pharmacotoxicol, Lyon, Auvergne Rhone, France

[9] CHU Dijon Bourgogne, Serv Med Interne & Malad Syst Med Interne 2, 14 Rue Paul Gaffarel,BP 77908, F-21079 Dijon, France

来源：

OPHTHALMOLOGY | 2024年 / 131卷 / 02期

关键词：

D O I：

10.1016/j.ophtha.2023.10.004

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：249 / 251

页数：3

共 7 条

[1] Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database [J].

Anquetil, Celine ;

Salem, Joe-Elie ;

Lebrun-Vignes, Benedicte ;

Touhami, Sara ;

Desbois, Anne-Claire ;

Maalouf, Georgina ;

Domont, Fanny ;

Allenbach, Yves ;

Cacoub, Patrice ;

Bodaghi, Bahram ;

Saadoun, David .

JOURNAL OF AUTOIMMUNITY, 2020, 111

[2] Updating the French Method for the Causality Assessment of Adverse Drug Reactions [J].

Arimone, Yannick ;

Bidault, Irene ;

Dutertre, Jean-Paul ;

Gerardin, Mark ;

Guy, Claire ;

Haramburu, Francoise ;

Hillaire-Buys, Dominique ;

Meglio, Carmine ;

Penfornis, Catherine ;

Theophile, Helene ;

Valnet-Rabier, Marie-Blanche .

THERAPIE, 2013, 68 (02) :69-76

[3] Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis [J].

Dick, Andrew D. ;

Tundia, Namita ;

Sorg, Rachael ;

Zhao, Chen ;

Chao, Jingdong ;

Joshi, Avani ;

Skup, Martha .

OPHTHALMOLOGY, 2016, 123 (03) :655-662

[4] Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes [J].

Dow, Eliot R. ;

Yung, Madeline ;

Tsui, Edmund .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) :203-211

[5] Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop [J].

Jabs, DA ;

Nussenblatt, RB ;

Rosenbaum, JT .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (03) :509-516

[6] Ocular Safety Profile of BRAF and MEK Inhibitors Data from the World Health Organization Pharmacovigilance Database [J].

Mettler, Camille ;

Monnet, Dominique ;

Kramkimel, Nora ;

Treluyer, Jean-Marc ;

Mouthon, Luc ;

Brezin, Antoine ;

Dupin, Nicolas ;

Valnet-Rabier, Marie-Blanche ;

Chouchana, Laurent ;

Terrier, Benjamin .

OPHTHALMOLOGY, 2021, 128 (12) :1748-1755

[7] Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001) [J].

Thiessard, F ;

Roux, E ;

Miremont-Salamé, G ;

Fourrier-Réglat, A ;

Haramburu, F ;

Tubert-Bitter, P ;

Bégaud, B .

DRUG SAFETY, 2005, 28 (08) :731-740

← 1 →